13-24434496-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006437.4(PARP4):āc.4645A>Gā(p.Ile1549Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006437.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP4 | NM_006437.4 | c.4645A>G | p.Ile1549Val | missense_variant | 31/34 | ENST00000381989.4 | NP_006428.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP4 | ENST00000381989.4 | c.4645A>G | p.Ile1549Val | missense_variant | 31/34 | 1 | NM_006437.4 | ENSP00000371419 | P1 | |
TPTE2P6 | ENST00000445572.5 | n.233+25192T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152256Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251278Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135804
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461508Hom.: 0 Cov.: 38 AF XY: 0.00000825 AC XY: 6AN XY: 727036
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2023 | The c.4645A>G (p.I1549V) alteration is located in exon 31 (coding exon 30) of the PARP4 gene. This alteration results from a A to G substitution at nucleotide position 4645, causing the isoleucine (I) at amino acid position 1549 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at